It improves glucose tolerance and β-cell function, inhibits α-glucosidase and DPP-IV activity, extends GLP-1/GIP half-life, and suppresses the release of IL-1β, IL-4, IL-6, and TNF-α, thereby delaying T2DM progression [191]. The gene discussed is IL4; the disease is type 2 diabetes mellitus.